AI-assisted, human-published
02/03/2025 /M & A
Tempus AI Completes Acquisition of Ambry Genetics
Tempus AI, Inc. has finalized the acquisition of Ambry Genetics, a leader in genetic testing. The acquisition aligns with Tempus' strategy of utilizing diagnostics and data to drive innovation and enhance solutions for patients, clinicians, and life sciences companies.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com